Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment".

Vanstraelen, Kim; Pauwels, Steven; Oyaert, Matthijs; Maertens, Johan; Spriet, Isabel

Vanstraelen, Kim; Pauwels, Steven; Oyaert, Matthijs; Maertens, Johan; Spriet, Isabel.

Affiliation

Vanstraelen K; *Clinical Pharmacology and Pharmacotherapy, KU Leuven Department of Pharmaceutical and Pharmacological Sciences Clinical Department of Laboratory Medicine, University Hospitals Leuven Clinical Department of Haematology, Acute Leukaemia and Stem Cell Transplantation Unit, University Hospitals Leuven, Leuven, Belgium.

Ther Drug Monit ; 37(4): 551-3, 2015 Aug.

Article in En | MEDLINE | ID: mdl-25525765

Subject(s)

Antifungal Agents/administration & dosage; Antifungal Agents/blood; Drug Monitoring/methods; Pre-Exposure Prophylaxis; Voriconazole/administration & dosage; Voriconazole/blood; Female; Humans; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Monitoring / Voriconazole / Pre-Exposure Prophylaxis / Antifungal Agents Limits: Female / Humans / Male Language: En Journal: Ther Drug Monit Year: 2015 Document type: Article Affiliation country: Belgium Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google